These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

13628 related articles for article (PubMed ID: 10683977)

  • 1. [Expression of CD44 molecule and its significance in uveal and conjunctival melanomas].
    Song J; Luo C; Xia R; Jiang S
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Mar; 29(1):38-41. PubMed ID: 10683977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective uveal melanoma inhibition with calcium channel blockade.
    Shaughnessy M; Lamuraglia G; Klebanov N; Ji Z; Rajadurai A; Kumar R; Flaherty K; Tsao H
    Int J Oncol; 2019 Nov; 55(5):1090-1096. PubMed ID: 31545410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI for the evaluation of scleral invasion and extrascleral extension of uveal melanomas.
    Récsán Z; Karlinger K; Fodor M; Zalatnai A; Papp M; Salacz G
    Clin Radiol; 2002 May; 57(5):371-6. PubMed ID: 12014934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.
    Refaian N; Schlereth SL; Koch KR; Notara M; Hos D; Mescher M; Iden S; Bosch JJ; Jager MJ; Cursiefen C; Heindl LM
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5691-7. PubMed ID: 26313304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleral patch grafts in the management of uveal and ocular surface tumors.
    Barman M; Finger PT; Milman T
    Ophthalmology; 2012 Dec; 119(12):2631-6. PubMed ID: 22858126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
    Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and clinical significance of pepsinogen C in uveal melanomas.
    Alvarez ML; González LO; Barbón JJ; Astudillo A; Vizoso FJ
    Int J Biol Markers; 2004; 19(3):240-4. PubMed ID: 15503827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo confocal microscopy of pigmented conjunctival tumors.
    Messmer EM; Mackert MJ; Zapp DM; Kampik A
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1437-45. PubMed ID: 16598465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas.
    Iwamoto S; Burrows RC; Grossniklaus HE; Orcutt J; Kalina RE; Boehm M; Bothwell MA; Schmidt R
    Arch Ophthalmol; 2002 Dec; 120(12):1625-9. PubMed ID: 12470134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior?
    Staibano S; Mascolo M; Tranfa F; Salvatore G; Mignogna C; Bufo P; Nugnes L; Bonavolontà G; De Rosa G
    Int J Immunopathol Pharmacol; 2006; 19(1):171-9. PubMed ID: 16569355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD44 and the pattern of CD44 alternative splicing in uveal melanoma.
    Danen EH; ten Berge PJ; van Muijen GN; Jager MJ; Ruiter DJ
    Melanoma Res; 1996 Feb; 6(1):31-5. PubMed ID: 8640067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular melanomas : An update].
    Kalirai H; Müller PL; Jaehne D; Coupland SE
    Pathologe; 2017 Nov; 38(6):491-499. PubMed ID: 29038913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma-associated spongiform scleropathy: biochemical changes and possible relation to tumour extension.
    Alyahya GA; Ribel-Madsen SM; Heegaard S; Prause JU; Trier K
    Acta Ophthalmol Scand; 2003 Dec; 81(6):625-9. PubMed ID: 14641266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
    Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
    Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive and noninvasive uveal melanomas have different adhesive properties.
    Woodward JK; Rennie IG; Elshaw SR; Burn JL; Sisley K
    Eye (Lond); 2005 Mar; 19(3):342-8. PubMed ID: 15258612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of neurotrophin receptors by retinoinvasive uveal melanoma.
    Milman T; Hu DN; McCormick SA; Eagle RC; Crawford JB; Chin K; Shields CL; Shields JA; Char DH; Finger PT
    Melanoma Res; 2012 Apr; 22(2):164-8. PubMed ID: 22343487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric metastases from conjunctival melanoma.
    Cohen VM; Ahmadi-lari S; Hungerford JL
    Melanoma Res; 2007 Aug; 17(4):255-6. PubMed ID: 17625457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
    Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 682.